Time Scale Financial, Inc. Alkermes Plc. Transaction History
Time Scale Financial, Inc.
- $462 Million
- Q2 2023
A detailed history of Time Scale Financial, Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Time Scale Financial, Inc. holds 80 shares of ALKS stock, worth $2,246. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80
Previous 80
-0.0%
Holding current value
$2,246
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
364Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$817 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$533 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$365 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$355 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$258 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.61B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...